Paradigm Biopharmaceuticals Limited

ASX:PAR.AX

0.47 (AUD) • At close January 24, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q2
Operating Activities:
Net Income -9.695-48.958-20.043-31.867-12.265-26.985-13.567-20.73-7.195-5.104-11.227-4.4-2.617-3.573-1.457-2.818-1.502-1.423-0.96-0.605-0.116-0.116
Depreciation & Amortization 0.0730.0730.0770.0770.0960.0970.1070.1030.140.0730.00800.01500.01700.00300000
Deferred Income Tax 0-3.846-8.43912.179-7.3537.587-6.5750.153-0.723-0.79-1.24500.13900.30601.28300000
Stock Based Compensation 0.370.830.0170.921.6911.5791.8541.3520.7870.4912.04200.78100.17900.05100.4840.26500
Change In Working Capital 1.452-3.046-7.58812.921-4.8339.272-3.73-0.006-0.0870.054-0.8430-0.9910-0.4850-1.33500.0040-0.36-0.36
Accounts Receivables 2.344-0.62-6.5426.4530.3341.454-5.010.012-0.2040.226-0.7970-0.920-0.4850-1.33500.0040-0.06-0.06
Change In Inventory 0000000000000000000000
Change In Accounts Payables 0-2.249-1.7266.799-5.8037.9050.5031.69900000000000000
Other Working Capital -0.892-0.1780.681-0.3310.636-0.0870.777-1.7170.117-0.172-0.0450-0.0710000000-0.3-0.3
Other Non Cash Items -7.1223.9248.543-11.9847.186-8.2786.262-0.1532.994-0.7856.8272.435-1.9692.3410.447-0.3530.0190.5990.005-0.3960.1670.167
Operating Cash Flow -14.922-51.023-27.432-17.754-15.477-16.728-15.648-19.281-4.201-5.889-4.4-1.965-4.781-1.233-1.299-3.171-2.764-0.823-0.467-0.736-0.309-0.309
Investing Activities:
Investments In Property Plant And Equipment 000000-0.011-0.021-0.032-0.099-0.0210-0-0.003-0.004-0.016-0.01-0.0030000
Acquisitions Net 00000000000000000.41-0.410000
Purchases Of Investments 0000000000000000000000
Sales Maturities Of Investments -0.0460.046-0.0460.046000.701.953.804000000000000
Other Investing Activites 00.046-0.0460.046000.7-0.0011.9523.798-6.504-0.0010.092-0.104-1.123-0.78-0.599-0.153-0.202-0.036-0.255-0.255
Investing Cash Flow -0.0460.046-0.0460.046-39.67471.0350.689-0.0211.9183.705-6.521-0.0010.092-0.107-1.127-0.795-0.199-0.567-0.202-0.036-0.255-0.255
Financing Activities:
Debt Repayment 0-0.0510-0.0560-0.0670-0.0590-0.037000000000000
Common Stock Issued -0.07528.354062.223000.5820.54233.4180.83373.32400000000000
Common Stock Repurchased 000000000000000000-1.235000
Dividends Paid 0000000000000000000000
Other Financing Activities -0.12628.3540.23662.3550.0570.0790.4160.6461.8530.81973.3249.4541.1334.751-0.0085.9930.6966.5311.7671.0270.5870.587
Financing Cash Flow -0.12628.3020.23662.2980.0570.0130.4160.58635.2710.78273.3249.4541.1334.751-0.0085.9930.6966.5310.5321.0270.5870.587
Other Information:
Effect Of Forex Changes On Cash -0.637-0.108-0.351-0.3390.110.6650.371103.922-103.92272.336-72.3362.446-2.4462.591-2.5912.998-2.9990.125-0.1250.00800
Net Change In Cash -15.73-22.782-27.59344.252-15.123-16.237-14.171-18.71632.98970.93462.4039.934-6.0026.002-5.0255.025-5.2665.266-0.2620.2620.0470.047
Cash At End Of Period 17.82133.55156.33383.92639.67454.79871.03585.206103.92270.93472.3369.93406.00205.02505.26600.2620.0470.047